PATHOMORPHOLOGICAL FEATURES OF MYOCARDIAL MICROCIRCULATION IN PERIPARTUM CARDIOMYOPATHY ACCORDING TO PREGNANCY PARITY

Narbayeva Shahnozakhon Zafar kizi

Andijan State Medical Institute, Andijan, Uzbekistan

Kadirov Komiljon Zakirdjanovich

PhD, Associate professor

Keywords: peripartum cardiomyopathy; myocardial microcirculation; pregnancy parity; endothelial injury; capillary remodeling; angiogenesis; sFLT1; prolactin; myocardial fibrosis.


Abstract

Peripartum cardiomyopathy (PPCM) is a form of heart failure that appears near the end of pregnancy or in the months following delivery. Although the clinical picture is dominated by reduced left ventricular function, changes in the small vessels that supply the myocardium may be an important part of the disease. Pregnancy-related antiangiogenic signals and hormonal changes may reduce capillary stability, while inflammatory and fibrotic reactions affect surrounding cardiac tissue. The possible influence of pregnancy parity on these changes is still unclear. Objective. To examine published morphological and experimental evidence of myocardial microcirculatory injury in PPCM and assess what can currently be concluded about its association with first and subsequent deliveries. Materials and methods. A descriptive comparative review of five publications concerning myocardial capillary ultrastructure, angiogenic imbalance, prolactin-related endothelial injury, and reproductive history was undertaken. Histological findings were considered separately from experimental mechanisms and population-based associations. Results. The reviewed literature describes endothelial remodeling, capillary lumen abnormalities, disturbed angiogenic signaling, and interstitial tissue changes. Experimental studies support roles for reduced angiogenic protection, increased sFLT1 activity, and a 16-kDa prolactin fragment. Clinical data suggest a relationship between parity and PPCM risk but do not provide reliable parity-specific measurements of myocardial capillary damage.


References

1. Wang X, Zheng K, Zhang Q. Risk Factors for Peripartum Cardiomyopathy: A Systematic Review and Meta-Analysis. Heart, Lung and Circulation. 2025. (Bibliographic details as reported in the supplied thesis; verify the final issue and page information before submission.)

2. Shani H, Kuperstein R, Berlin A, Arad M, Goldenberg I, Simchen MJ. Peripartum cardiomyopathy - risk factors, characteristics and long-term follow-up. Journal of Perinatal Medicine. 2015;43(1):95–101. doi:10.1515/jpm-2014-0086.

3. Fidzianska A, Walczak E, Glinka Z, Religa G, Sobieszczanska-Malek M, Bilinska ZT. Ultrastructural evidence of myocardial capillary remodeling in peripartum cardiomyopathy. Medical Science Monitor. 2010;16(5):CS62–CS66. PMID:20424558.

4. Patten IS, Rana S, Shahul S, et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012;485(7398):333–338. doi:10.1038/nature11040.

5. Hilfiker-Kleiner D, Kaminski K, Podewski E, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007;128(3):589–600. doi:10.1016/j.cell.2006.12.036.